Forensics Specialist Discusses a Discipline in Crisis
By Daniel Cressey,
Nature News
| 02. 12. 2015
Untitled Document
Solid scientific evidence can be crucial for solving crimes. But science may have been progressing too fast for the courts and the juries to keep up. The problem was symbolized by a ruling last year in which Mark Dwyer, a judge of the New York State Supreme Court, declared that a forensic-analysis technique known as low-copy-number DNA testing was inadmissible because there was no consensus in the scientific community that it was valid forensic tool. The technique, which consists of amplifying very small amounts of DNA to obtain a profile, has been used to get convictions in various countries but has been criticized as being susceptible to contamination and having problems with reproducibility.
To help to bridge the divide between law and lab, leading forensic scientists held a meeting with senior legal experts in London earlier this month.
Nature spoke to Niamh Nic Daéid of the University of Dundee, UK, who co-organized the meeting with fellow Dundee forensics expert Sue Black. One of Britain's leading forensic scientists, Nic Daéid works at Dundee's Centre for Anatomy and Human Identification...
Related Articles
By Emma Cieslik, Ms. Magazine | 11.20.2025
Several recent Biopolitical Times posts (1, 2, 3, 4) have called attention to the alarmingly rapid commercialization of “designer baby” technologies: polygenic embryo screening (especially its use to purportedly screen for traits like intelligence), in vitro gametogenesis (lab-made eggs and sperm), and heritable genome editing (also termed embryo editing or reproductive gene editing). Those three, together with artificial wombs, have been dubbed the “Gattaca stack” by Brian Armstrong, CEO of the cryptocurrency company...
By Adam Feuerstein, Stat | 11.20.2025
The Food and Drug Administration was more than likely correct to reject Biohaven Pharmaceuticals’ treatment for spinocerebellar ataxia, a rare and debilitating neurodegenerative disease. At the very least, the decision announced Tuesday night was not a surprise to anyone paying attention. Approval...
By Emily Glazer, Katherine Long, Amy Dockser Marcus, The Wall Street Journal | 11.08.2025
For months, a small company in San Francisco has been pursuing a secretive project: the birth of a genetically engineered baby.
Backed by OpenAI chief executive Sam Altman and his husband, along with Coinbase co-founder and CEO Brian Armstrong, the startup—called...